Baidu
map

实用:泵药物的配置公式

2015-01-08 伊文 医学之声

        硝酸甘油 50mg + NS40ml 0.6ml/h (10ug/min)         硝普钠 50mg + NS 50ml 0.6ml/h (10ug/min)    

        硝酸甘油 50mg + NS40ml 0.6ml/h (10ug/min)

        硝普钠 50mg + NS 50ml 0.6ml/h (10ug/min)

        多巴胺 200mg + NS 30ml 4ml/h (5ug/kg/min)

        多巴酚丁胺 200mg +NS 30ml 4ml/h (5ug/kg/min)

        去甲肾上腺素 50mg +NS 25 mL 1.5ml/h (0.5ug/kg/min)

        胰岛素 50u +NS50ml 5ml/h (0.1u/kg/h kg=50)

        阿端(哌库溴铵)0.08mg~0.1mg/kg 4mg~5mg 肾功能不全不超过0.04mg/kg2mg

        仙林(维库溴铵) 70~100ug/kg 3.5~5mg/h (kg=50)

        仙林(维库溴铵) 首剂 0.08~0.1mg/kg 补充 0.03~0.05mg/kg

        咪唑安定 15mg + NS15 ml 2ml/h (2mg/h)

        施他宁 3mg + NS50ml 4.1ml/h (250ug/h)

        吗啡 10mg + NS9ml

        可达龙(胺碘酮) 首剂150 mg + NS 20 ml,维持 300 mg + NS 44ml ≤6 ml(35mg/h)

        胺碘酮 首剂 5~10mg/kg iv ,维持 300mg ivgtt ≤30min

        异丙酚 首剂 40mg 维持 40mg/h

        尼莫同 起始2小时 1mg/h(>70kg) 或0.5mg/h(<50kg),可耐受者2小时后 2mg/h

        氨茶碱 起始 250mg+ NS 40ml (30min内),维持 500mg+NS50ml (5ml/h)

        利尿合剂 5%葡萄糖 250ml +多巴胺 20mg+立其丁 5~10mg+速尿 80mg

        地高辛 首剂 1~1.5mg/d ,维持量 0.25~0.5mg/d

        多巴酚丁胺 20~40mg+100mlGS(40~120mg/d) 2.5—10ug/kg/min

        利多卡因 首剂 50mg iv 无效 100mg /5~10min (≤500~800mg),维持 400mg +GS 500ml (≤1000~1500mg/d)

        去甲肾上腺素 首剂 2mg/次 8~12ug/min 维持 2~4ug/min

        阿拉明 0.015~0.1g + NS 500ml ( 0.2~0.4mg/min)

        常用药物输注计算:

        常用药物用量配法算

        多巴胺:(公斤体重×3)mg 稀释至50ml 如泵速为1ml/h,泵入量为1μg/(kg.min) ,常用剂量1~20μg/(kg.min);起始剂量5μg/(kg.min);

        多巴酚丁胺:配法同多巴胺,常用剂量1~20μg/(kg.min),起始剂量1μg/(kg.min);

        硝普钠:5%GS 50ml+硝普钠 50mg,即1mg/ml(1000μg/ml),常用剂量10~200μg/min或0.1~2μg/(kg.min),起始剂量5~10μg/min(0.3~0.6ml/h)。

        硝酸甘油:(公斤体重×0.3)mg 稀释至50ml 如泵速为1ml/h,泵入量为0.1μg/(kg.min) 或:NS 44ml+硝酸甘油30mg,即0.6mg/ml(600μg/ml),常用剂量10~200μg/min或0.1~2μg/(kg.min),起始剂量5~10μg/min(0.5~1ml/h)。

        去甲肾上腺素:(公斤体重×0.3)mg 稀释至50ml 如泵速为1ml/h,泵入量为0.1μg/(kg.min)常用剂量0.1~2μg/(kg.min),起始剂量0.1μg/(kg.min)(应经中心静脉使用去甲肾上腺素)

        肾上腺素:配法同去甲肾上腺素,起始剂量为0.1μg/(kg.min),常用剂量为0.1~1μg/(kg.min)(尽可能经中心静脉用药)严重低血压及过敏性休克0.3~0.5mg ih或iv

        异丙肾上腺素:(公斤体重×0.03)mg 稀释至50ml 如泵速为1ml/h,泵入量为0.01μg/(kg.min)起始剂量0.01μg/(kg.min),以目标心率为终点。

        胺碘酮:胺碘酮450mg用5%葡萄糖稀释到45ml,即10mg/ml,150mg iv bolus(10分钟),60mg/h×6h,30mg/h×18h,20mg/h维持3天,24小时总量不超过1.2g

        心律平:规格70mg/20ml 70mg用5%葡萄糖液稀释到50ml,iv bolus(10分钟),密切观察心率及心律,室速或室上速转复后立即停止注射。必要时20分钟后可重复,总量不超过210mg。

        肝素:肝素1支(12500u)加NS至12.5ml,配制成1000U/ml,肝素化时:75U/kg iv bolus,继以18U/kg h静脉泵入,调整剂量使aPTT-R维持在1.5~2.5。

        吗啡:配制成1㎎/ml(20㎎/20ml,或50mg/50ml),5mg iv bolus,继以3mg/h泵入,<1mg/kg。

        常用静脉泵入药物的配制及应用方法(供参考)

        立其丁:NS45ml+立其丁50mg配制成1mg/ml(1000μg/ml),常用剂量300~500μg/min,起始剂量为100μg/min静脉泵入。

        利多卡因:抽取原液5支(200mg/10ml/支)即20 mg/ml,首剂1.5mg/kg iv bolus,无效可每隔8分钟重复0.5mg/kg直到总量达3mg/kg,复律成功后2~4mg/min维持。

        垂体后叶素:NS 30ml+垂体后叶素60U,即2 U/ml,消化道出血常用剂量0.2~0.4 U/min;咯血常用剂量0.1 U/min;尿崩症患者根据尿量调整,起始剂量0.1~0.2 U/min;感染性休克顽固性低血压患者,常用剂量为0.01~0.04 U/min。

        施他宁:配制成250μg/ml,先给负荷量250μg iv bolus,然后以250μg/h静脉泵入。

        安定:先10mg ivbolus,继以5mg/h泵入,最大100mg/d.

        德巴金(注射用丙戊酸钠):规格400mg/支 配制成10mg/ml,首剂400mg(15mg/kg), iv bolus,大于5分钟,维持60mg/h(1~2mg/kg/h).

        尼莫同:规格10mg/50ml起始量0.2mg/h(1ml/h),根据血压情况依次递增至全量2mg/h,维持到蛛网膜下腔出血后的10~14天。

        氨茶碱:0.5 稀释至50ml配制成10mg/ml,成人负荷剂量5mg/kg, iv bolus,速度<25mg/min.(一般成人氨茶碱0.25,静注15分钟即可)维持剂量0.5~0.7mg/kg/h。可从20mg/h(2ml/h)开始。

        胰岛素:配制成1U/ml,起始速度1U/h,根据血糖调整。

        阿曲库铵:首剂 0.3~0.5mg/kg (标准速度9~10ug/(kg.min), iv,再5~9ug/(kg.min)维持

        硫酸镁:负荷剂量25%硫酸镁10ml稀释1倍,iv bolus.维持剂量:25%硫酸镁4.0加入5%葡萄糖溶液或生理盐水250ml,1~3ml/min

        维库溴铵:首剂0.075mg/kg iv,再0.075mg/(kg.h)维持

        芬太尼: 先负荷4~20u/(kg.h),再维持2~10u/(kg.h)

        奥曲肽: 初始量0.1mg iv(>5min),再维持0.025~0.05mg/h

        咪达唑仑: 先iv 2~3mg/kg,再维持0.05mg/(kg.h)

        双异丙酚: 0.3~0.4mg/(kg.h)泵入,规格200mg/20ml

        依托咪酯:10ug/(kg.min) 泵入 规格20mg/10ml


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=48013, encodeId=2efa480137a, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 14:26:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28157, encodeId=37d42815eef, content=这个一定要收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de0c93797, createdName=AugustWen, createdTime=Thu Jun 18 22:15:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24131, encodeId=c907241315a, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9da1623000, createdName=darkdaisy, createdTime=Tue May 19 15:17:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14897, encodeId=8a4a1489e0c, content=总结很全面,学习了。我们也是这样用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9c21612116, createdName=tutu159, createdTime=Fri Jan 30 21:18:00 CST 2015, time=2015-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14008, encodeId=aa791400831, content=good!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Mon Jan 12 10:05:00 CST 2015, time=2015-01-12, status=1, ipAttribution=)]
    2015-12-26 hixiaoluo

    很有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=48013, encodeId=2efa480137a, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 14:26:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28157, encodeId=37d42815eef, content=这个一定要收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de0c93797, createdName=AugustWen, createdTime=Thu Jun 18 22:15:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24131, encodeId=c907241315a, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9da1623000, createdName=darkdaisy, createdTime=Tue May 19 15:17:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14897, encodeId=8a4a1489e0c, content=总结很全面,学习了。我们也是这样用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9c21612116, createdName=tutu159, createdTime=Fri Jan 30 21:18:00 CST 2015, time=2015-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14008, encodeId=aa791400831, content=good!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Mon Jan 12 10:05:00 CST 2015, time=2015-01-12, status=1, ipAttribution=)]
    2015-06-18 AugustWen

    这个一定要收藏!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=48013, encodeId=2efa480137a, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 14:26:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28157, encodeId=37d42815eef, content=这个一定要收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de0c93797, createdName=AugustWen, createdTime=Thu Jun 18 22:15:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24131, encodeId=c907241315a, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9da1623000, createdName=darkdaisy, createdTime=Tue May 19 15:17:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14897, encodeId=8a4a1489e0c, content=总结很全面,学习了。我们也是这样用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9c21612116, createdName=tutu159, createdTime=Fri Jan 30 21:18:00 CST 2015, time=2015-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14008, encodeId=aa791400831, content=good!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Mon Jan 12 10:05:00 CST 2015, time=2015-01-12, status=1, ipAttribution=)]
    2015-05-19 darkdaisy

    全面

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=48013, encodeId=2efa480137a, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 14:26:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28157, encodeId=37d42815eef, content=这个一定要收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de0c93797, createdName=AugustWen, createdTime=Thu Jun 18 22:15:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24131, encodeId=c907241315a, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9da1623000, createdName=darkdaisy, createdTime=Tue May 19 15:17:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14897, encodeId=8a4a1489e0c, content=总结很全面,学习了。我们也是这样用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9c21612116, createdName=tutu159, createdTime=Fri Jan 30 21:18:00 CST 2015, time=2015-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14008, encodeId=aa791400831, content=good!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Mon Jan 12 10:05:00 CST 2015, time=2015-01-12, status=1, ipAttribution=)]
    2015-01-30 tutu159

    总结很全面,学习了。我们也是这样用的。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=48013, encodeId=2efa480137a, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 14:26:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=28157, encodeId=37d42815eef, content=这个一定要收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de0c93797, createdName=AugustWen, createdTime=Thu Jun 18 22:15:00 CST 2015, time=2015-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24131, encodeId=c907241315a, content=全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9da1623000, createdName=darkdaisy, createdTime=Tue May 19 15:17:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14897, encodeId=8a4a1489e0c, content=总结很全面,学习了。我们也是这样用的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9c21612116, createdName=tutu159, createdTime=Fri Jan 30 21:18:00 CST 2015, time=2015-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14008, encodeId=aa791400831, content=good!, beContent=null, objectType=article, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Mon Jan 12 10:05:00 CST 2015, time=2015-01-12, status=1, ipAttribution=)]
    2015-01-12 MedSci客户端网友

    good!

    0

相关资讯

JACC:6分钟步行试验可确认ICD治疗无法获益患者

美国一项研究表明,利用基线6分钟步行试验(SMV)距离小于288米可确认无法从ICD治疗中获益并且胺碘酮治疗有害的亚组患者。论文于4月9日在线发表于《美国心脏病学会杂志》(J Am Coll Cardiol)。 SCD-HeFT试验显示NYHA III级患者未能从ICD中获益并且胺碘酮治疗可能有害,NYHA II级患者则可从ICD中得到显著生存获益,但尚不清楚是否存在更为客观的功能指标。此项研究

JCE:既往存在胺碘酮相关甲亢的房颤患者导管消融后复发率较高

环肺静脉消融术是心房颤动的有效治疗手段,近年来随着消融技术的进展,越来越多的患者通过导管消融术根治了房颤,然而我们也认识到导管消融治疗房颤存在较高的复发率,因此寻找房颤复发的预测因素具有重要意义,既往多项临床研究表明左心房大小、高血压、高血糖及房颤的持续时间是房颤复发的预测因素,也有部分临床表明房颤后新发房性心动过速、持续性房颤、大面积的环肺静脉消融和左心房线状消融可预测房颤复发。目前认为存在并发

Eur Heart J:房颤患者消融后短期口服胺碘酮喜忧参半

ESC2014公布的一项研究表明,阵发性或永久性心房颤动(简称房颤)患者消融后短期口服胺碘酮治疗未显著减少其房性快速性心律失常的复发,但在消退期,这种治疗方法可将房性心律失常相关住院率和心脏电复律减半甚至更少。论文9月2日在线发表于《欧洲心脏杂志》(Eur Heart J)。 接受导管消融治疗的房颤患者常在消融后数月内反复发生心律失常。该研究旨在探讨房颤射频消融后早期预防性短期应用胺碘酮是否可以

胡大一:心血管药物应使用“中国剂量”!

胺碘酮 我认真回忆了众多有关剂量的故事。1985-1987年在美国做访问学者时,我发现美国医生使用胺碘酮的负荷剂量为1200-1800mg/d,维持量为600-800mg/d,甲状腺功能异常与肺间质纤维化的严重不良反应引起人们的极大关注。回国后,看到黄宛教授使用胺碘酮的剂量远远小于美国剂量,他用的负荷剂量为600mg/d,维持量200mg/d,甚至更小。不但疗效好,而且不良反应明显小于美

Baidu
map
Baidu
map
Baidu
map